Inhibition of miR-214 expression by small molecules alleviates head and neck cancer metastasis by targeting ALCAM/TFAP2 signaling.
A. Agarwal, V. Kansal, H. Farooqi, R. Prasad, V. K. Singh
This study shows that inhibiting miR-214 with EGCG reduces head and neck cancer metastasis by targeting ALCAM/TFAP2 signaling.
bioRxiv · Apr 4, 2023 · PreprintCancer Biology